Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of PLL001 in ALS Patients
Phase 1
Recruiting
- Conditions
- Amyotrophic Lateral SclerosisALS
- Interventions
- Drug: PLL001 or placebo daily subcutaneous injections
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- PLL TX AUSTRALIA PTY LTD
- Target Recruit Count
- 153
- Registration Number
- NCT06513546
- Locations
- 🇦🇺
Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺Neuroscience Research Australia, Sidney, New South Wlaes, Australia
🇦🇺Sunshine Coast University Hospital, Birtinya, Queensland, Australia
News
No news found